{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARGNF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARGNF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARGNF\",,,,,undefined,":{"symbol":"ARGNF","market":"US","secType":"STK","nameCN":"Argen X NV","latestPrice":569.1925,"timestamp":1750795200000,"preClose":586.545,"halted":0,"volume":2,"delay":15,"floatShares":59396720,"shares":59796273,"eps":-3.467175,"marketStatus":"Not Yet Opened","change":-17.3525,"latestTime":"06-24 16:00:00 EDT Delay","open":569.1925,"high":569.1925,"low":569.1925,"amount":1138.385,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-3.467175,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750838400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":586.545,"volumeRatio":0.059171},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARGNF\",,,,,undefined,":{"symbol":"ARGNF","floatShares":59396720,"roa":"-0.21%","roe":"17.36%","lyrEps":-5.161043,"volumeRatio":0.059171,"shares":59796273,"dividePrice":0,"high":569.1925,"amplitude":0,"preClose":586.545,"low":569.1925,"week52Low":373.5,"pbRate":"6.19","psRate":"12.88","week52High":697.42,"institutionHeld":0,"latestPrice":569.1925,"eps":-3.467175,"divideRate":0,"volume":2,"delay":15,"ttmEps":-3.467175,"open":569.1925,"prevYearClose":652.35,"prevWeekClose":586.545,"prevMonthClose":562,"prevQuarterClose":697.42,"fiveDayClose":586.545,"twentyDayClose":562,"sixtyDayClose":697.42},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARGNF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARGNF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532191023","title":"Is argenx SE (ARGX) the Most Profitable Growth Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532191023","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532191023?lang=en_us&edition=fundamental","pubTime":"2025-05-01 15:33","pubTimestamp":1746084826,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Most Profitable Growth Stocks to Buy Now. In this article, we are going to take a look at where argenx SE  stands against other most profitable growth stocks to buy now.READ ALSO:10 Most Profitable Blue Chip Stocks to Buy Now. Business surveys have also been quite grim – Hamilton Lane recently reported that at least 62% of CEOs see a recession on the horizon, while the 6-month Capex expectations fell to the lowest level since the pandemic. It is now clear that pretty much everyone is thinking about a recession now, and that’s ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argenx-se-argx-most-profitable-073346468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","USAW.SI","USJW.SI","MNQmain","QID","NQmain","LU0320765992.SGD","LU0109394709.USD","BK4585","TQQQ","BK4139","BK4505","BK4588","PSQ","TSYW.SI",".IXIC","ARGX","LU0889565916.HKD","NVIW.SI","ARGNF","SQQQ"],"gpt_icon":1},{"id":"2532904297","title":"Exploring High Growth Tech Stocks In Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2532904297","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532904297?lang=en_us&edition=fundamental","pubTime":"2025-05-01 13:40","pubTimestamp":1746078009,"startTime":"0","endTime":"0","summary":"As European markets experience a notable upswing, with the STOXX Europe 600 Index rising by 2.77% amid easing trade tensions and positive economic signals, investors are increasingly focusing on high-growth tech stocks that show resilience and potential in such dynamic conditions. In this environment, a good stock is often characterized by its ability to adapt to market changes and leverage technological advancements to drive growth, making it a key consideration for those exploring opportunities in Europe's burgeoning tech sector.Click here to see the full list of 221 stocks from our European High Growth Tech and AI Stocks screener.Remedy Entertainment Oyj, amidst a challenging landscape for tech firms, has demonstrated resilience with an 18.9% annual revenue growth, outpacing the Finn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-high-growth-tech-stocks-054009674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OTGLY","BK4588","BK4585","OTGLF","ARGX","BK4116","RMDEF","LU0320765992.SGD","BK4139","ARGNF","LU0889565916.HKD","CD","BK4505","LU0109394709.USD"],"gpt_icon":0},{"id":"2532104431","title":"argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532104431","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532104431?lang=en_us&edition=fundamental","pubTime":"2025-05-01 13:00","pubTimestamp":1746075600,"startTime":"0","endTime":"0","summary":"May 1, 2025Amsterdam, the Netherlands – argenx , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 8, 2025 at 2:30 p.m. CET  to discuss its first quarter 2025 financial results and provide a business update.Belgium 32 800 50 201France  33 800 943355Netherlands 31 20 795 1090United Kingdom 44 800 358 0970United States 1 888 415 4250Japan  81 3 4578 9081Switzerland 41 43 210 11 32. Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argenx-report-first-quarter-2025-050000914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4505","ARGNF","BK4585","BK4588","LU0320765992.SGD","ARGX","BK4139"],"gpt_icon":0},{"id":"2530700414","title":"argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530700414","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530700414?lang=en_us&edition=fundamental","pubTime":"2025-04-28 13:00","pubTimestamp":1745816400,"startTime":"0","endTime":"0","summary":"VYVGART is first-and-only targeted IgG Fc-antibody fragment for CIDP. First novel mechanism of action for CIDP treatment in more than 30 years. CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial. European Commission  decision on marketing authorization application expected within approximately two months. “Our mission is to develop innovative, targeted treatments for patients with rare and severe autoimmune diseases, who continue to face significant unmet needs. The positive CHMP opinion for VYVGART in CIDP brings us one step closer to providing patients across Europe with a transformational new treatment option that provides meaningful functional improvement,” said Luc Truyen M.D., Ph.D., Chief Medical Officer, argenx. “VYVGART is the first and only targeted IgG Fc-antibody fragment for CIDP and if approved, would mark the first treatment in Europe with a novel, precision mechanism of action for CIDP patients in 30 years.”\"For the patient population repre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argenx-announces-positive-chmp-opinion-050000869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARGX","BK4215","BK4087","BK4201","BK4139","MAA","BK4585","CHMP","BK4588","ARGNF","EC"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARGNF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"ARGNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715241600000,"name":null,"time":"Pre-Market","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2022-10-27","symbol":"ARGNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1666843200000,"reportTimeType":"pre","actualEps":null},{"date":"2022-05-12","symbol":"ARGNF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1652342400000,"name":null,"time":"","dateTimestamp":1652328000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARGNF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARGNF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.65,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1744689600000}}}